AU2019364677B2 - Algal extract for use in the treatment or prevention of post-traumatic immunosuppression - Google Patents

Algal extract for use in the treatment or prevention of post-traumatic immunosuppression Download PDF

Info

Publication number
AU2019364677B2
AU2019364677B2 AU2019364677A AU2019364677A AU2019364677B2 AU 2019364677 B2 AU2019364677 B2 AU 2019364677B2 AU 2019364677 A AU2019364677 A AU 2019364677A AU 2019364677 A AU2019364677 A AU 2019364677A AU 2019364677 B2 AU2019364677 B2 AU 2019364677B2
Authority
AU
Australia
Prior art keywords
algal extract
ulva
sulfated
trauma
cells
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2019364677A
Other languages
English (en)
Other versions
AU2019364677A1 (en
Inventor
Karim Asehnoune
Hervé BALUSSON
Marwan BOURAS
Hervé DEMAIS
Cédric JACQUELINE
Pi NYVALL-COLLÉN
Antoine ROQUILLY
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Amadeite SAS
Original Assignee
Amadeite SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Amadeite SAS filed Critical Amadeite SAS
Publication of AU2019364677A1 publication Critical patent/AU2019364677A1/en
Application granted granted Critical
Publication of AU2019364677B2 publication Critical patent/AU2019364677B2/en
Priority to AU2025200105A priority Critical patent/AU2025200105A1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/13—Preparation or pretreatment of starting material involving cleaning, e.g. washing or peeling
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10—Preparation or pretreatment of starting material
    • A61K2236/15—Preparation or pretreatment of starting material involving mechanical treatment, e.g. chopping up, cutting or grinding
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/50—Methods involving additional extraction steps
    • A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AU2019364677A 2018-10-22 2019-10-22 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression Active AU2019364677B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2025200105A AU2025200105A1 (en) 2018-10-22 2025-01-08 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1859721A FR3087338B1 (fr) 2018-10-22 2018-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique
FR1859721 2018-10-22
PCT/EP2019/078757 WO2020083931A1 (fr) 2018-10-22 2019-10-22 Extrait d'algues pour son utilisation pour le traitement ou la prevention de l'immunosuppression post-traumatique

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2025200105A Division AU2025200105A1 (en) 2018-10-22 2025-01-08 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression

Publications (2)

Publication Number Publication Date
AU2019364677A1 AU2019364677A1 (en) 2021-05-20
AU2019364677B2 true AU2019364677B2 (en) 2024-10-10

Family

ID=65494363

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2019364677A Active AU2019364677B2 (en) 2018-10-22 2019-10-22 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
AU2025200105A Pending AU2025200105A1 (en) 2018-10-22 2025-01-08 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2025200105A Pending AU2025200105A1 (en) 2018-10-22 2025-01-08 Algal extract for use in the treatment or prevention of post-traumatic immunosuppression

Country Status (10)

Country Link
US (1) US12377126B2 (https=)
EP (2) EP3870198B1 (https=)
JP (1) JP7614105B2 (https=)
KR (1) KR102922546B1 (https=)
CN (1) CN113347984A (https=)
AU (2) AU2019364677B2 (https=)
CA (1) CA3116952A1 (https=)
FR (1) FR3087338B1 (https=)
IL (1) IL282511B1 (https=)
WO (1) WO2020083931A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114376233A (zh) * 2022-03-23 2022-04-22 青岛海大生物集团股份有限公司 一种具有增强免疫功能的浒苔多糖保健食品及制备方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015071497A1 (fr) * 2013-11-18 2015-05-21 Amadeite Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7132101B2 (en) 2002-02-27 2006-11-07 Duquesne University Of The Holy Ghost Compositions and methods for eliciting an immune response to gram-negative bacterial infections
NZ542791A (en) 2003-04-08 2008-04-30 Biotempt Bv Compositions for mucosal and oral administration comprising HCG fragments
RU2417093C2 (ru) 2005-06-24 2011-04-27 Дезерт Лейк Текнолоджиз Очищенный компонент цианобактерий и способ применения
ATE514950T1 (de) 2007-09-07 2011-07-15 Univ Zuerich Verfahren zur untersuchung von sepsis bei menschen
KR101102829B1 (ko) * 2008-09-12 2012-01-05 재단법인 제주테크노파크 구멍갈파래 추출물과 그것의 항염증제로서의 용도
US9370537B2 (en) * 2009-04-03 2016-06-21 Cerule, Llc Compositions and methods for reducing inflammation
FR2954703B1 (fr) * 2009-12-28 2013-12-13 Chu Nantes Agonistes des recepteurs tlr 4 et 9 pour prevenir les complications septiques de l'immunodepression post-traumatique chez les patients hospitalises pour traumatismes severes
US20130102662A1 (en) * 2011-06-09 2013-04-25 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Use of inducible nitric oxide synthase inhibitors and nitric oxide scavengers to inhibit post-traumatic immunodepression
FR2999084B1 (fr) * 2012-12-11 2015-03-13 Amadeite Extrait d'algues comprenant en particulier des polysaccharides polyanioniques sulfates et non sulfates et ses applications
FR3013223B1 (fr) * 2013-11-18 2016-09-02 Amadeite Extrait d'algues pour son utilisation en tant qu'agent anti-bacterien

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015071497A1 (fr) * 2013-11-18 2015-05-21 Amadeite Extrait d'algues pour son utilisation en tant qu'agent immunomodulateur

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
WO 2015/071497 A1 US10912805 B2 used as English language version. *

Also Published As

Publication number Publication date
US20210386808A1 (en) 2021-12-16
US12377126B2 (en) 2025-08-05
AU2019364677A1 (en) 2021-05-20
KR102922546B1 (ko) 2026-02-04
AU2025200105A1 (en) 2025-01-23
BR112021007506A2 (pt) 2021-07-27
IL282511A (en) 2021-06-30
JP2022508900A (ja) 2022-01-19
WO2020083931A1 (fr) 2020-04-30
EP4483961A3 (fr) 2025-03-19
EP4483961A2 (fr) 2025-01-01
FR3087338B1 (fr) 2020-10-09
EP3870198C0 (fr) 2024-11-20
EP3870198A1 (fr) 2021-09-01
JP7614105B2 (ja) 2025-01-15
KR20210114921A (ko) 2021-09-24
IL282511B1 (en) 2026-02-01
EP3870198B1 (fr) 2024-11-20
CA3116952A1 (fr) 2020-04-30
FR3087338A1 (fr) 2020-04-24
CN113347984A (zh) 2021-09-03

Similar Documents

Publication Publication Date Title
US8404250B2 (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation
KR20160110336A (ko) 포유동물 체내에서 유래된 세포밖 소포체를 포함하는 조성물 및 이의 용도
Tang et al. Porphyromonas endodontalis lipopolysaccharides induce RANKL by mouse osteoblast in a way different from that of Escherichia coli lipopolysaccharide
AU2025200105A1 (en) Algal extract for use in the treatment or prevention of post-traumatic immunosuppression
JP2022508900A5 (https=)
BR112021007506B1 (pt) Uso de um extrato de algas verdes do tipo ulva
US8105601B2 (en) Compositions and methods for modulating an immune response
Radomska-Leśniewska et al. The effect of clindamycin and lincomycin on angiogenic activity of human blood mononuclear cells
KR101828044B1 (ko) 수지상 세포 및 항생제를 포함하는 결핵 예방 또는 치료용 조성물
KR101478827B1 (ko) 마이코박테리움 파라튜버큘로시스 ＭＡＰ１９８１ｃ 단백질을 유효성분으로 포함하는 수지상 세포의 성숙화 유도용 조성물
Santosa et al. THE EFFECT OF MORINGA LAM LEAF EXTRACT ON PHAGOCYTOSIS ACTIVITY OF MACROPHAGES, ROS, NO, IFN-γ, AND IL-10 ON PBMC IN ADULT PULMONARY TUBERCULOSIS PATIENTS INDUCED BY ESAT-6 IN-VITRO
Pilichiewicz et al. Sa2068 The Effect of the Probiotic Escherichia coli Nissle 1917 on Symptom Patterns and Immune Response in Patients Suffering From Diarrhoea Predominant Irritable Bowel Syndrome
HK1067073B (en) Gram positive bacteria preparations for the treatment of diseases comprising an immune dysregulation

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)